- Home
- ACXP vs TNON Comparison
ACXP vs TNON Comparison
Compare ACXP & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- TNON
- Stock Information
- Founded
- ACXP 2017
- TNON 2012
- Country
- ACXP United States
- TNON United States
- Employees
- ACXP N/A
- TNON N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- ACXP Health Care
- TNON Health Care
- Exchange
- ACXP Nasdaq
- TNON Nasdaq
- Market Cap
- ACXP 8.4M
- TNON 6.9M
- IPO Year
- ACXP 2021
- TNON 2022
- Fundamental
- Price
- ACXP $0.31
- TNON $1.46
- Analyst Decision
- ACXP Strong Buy
- TNON Strong Buy
- Analyst Count
- ACXP 2
- TNON 3
- Target Price
- ACXP $10.00
- TNON $11.67
- AVG Volume (30 Days)
- ACXP 920.6K
- TNON 11.9M
- Earning Date
- ACXP 08-12-2025
- TNON 08-12-2025
- Dividend Yield
- ACXP N/A
- TNON N/A
- EPS Growth
- ACXP N/A
- TNON N/A
- EPS
- ACXP N/A
- TNON N/A
- Revenue
- ACXP N/A
- TNON $3,284,000.00
- Revenue This Year
- ACXP N/A
- TNON $39.03
- Revenue Next Year
- ACXP N/A
- TNON $66.24
- P/E Ratio
- ACXP N/A
- TNON N/A
- Revenue Growth
- ACXP N/A
- TNON 2.18
- 52 Week Low
- ACXP $0.29
- TNON $0.85
- 52 Week High
- ACXP $2.39
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- ACXP 33.75
- TNON 75.09
- Support Level
- ACXP $0.30
- TNON $0.97
- Resistance Level
- ACXP $0.50
- TNON $1.11
- Average True Range (ATR)
- ACXP 0.05
- TNON 0.15
- MACD
- ACXP -0.02
- TNON 0.02
- Stochastic Oscillator
- ACXP 7.86
- TNON 32.45
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.